2001
The Effect of Institutional Fiscal Stress on the Use of Atypical Antipsychotic Medications in the Treatment of Schizophrenia
LESLIE D, ROSENHECK R. The Effect of Institutional Fiscal Stress on the Use of Atypical Antipsychotic Medications in the Treatment of Schizophrenia. The Journal Of Nervous And Mental Disease 2001, 189: 377-383. PMID: 11434638, DOI: 10.1097/00005053-200106000-00005.Peer-Reviewed Original ResearchMeSH KeywordsAlzheimer DiseaseAntipsychotic AgentsBenzodiazepinesBudgetsClozapineComorbidityDepressive DisorderDrug CostsFemaleHealth Care CostsHealth FacilitiesHumansMaleMiddle AgedOlanzapinePirenzepinePractice Patterns, Physicians'Regression AnalysisRisperidoneSchizophreniaTreatment OutcomeUnited StatesUnited States Department of Veterans AffairsConceptsAtypical antipsychotic medicationsTreatment of schizophreniaAtypical antipsychoticsAntipsychotic medicationExpensive atypical antipsychotic medicationsVeterans AffairsPrescription drug recordsGeneralized estimation equationsDrug recordsPatientsReduced likelihoodAntipsychoticsMedicationsFacility characteristicsSchizophreniaAtypicalsFinal sampleTreatmentOlanzapineRisperidone
1990
The Impact of DRG-Based Budgeting on Inpatient Psychiatric Care in Veterans Administration Medical Centers
Rosenheck R, Massari L, Astrachan B. The Impact of DRG-Based Budgeting on Inpatient Psychiatric Care in Veterans Administration Medical Centers. Medical Care 1990, 28: 124-134. PMID: 2105414, DOI: 10.1097/00005650-199002000-00003.Peer-Reviewed Original ResearchConceptsDiagnosis-related groupsInpatient psychiatric carePsychiatric careUnique patientsVeterans Administration Medical CenterVeterans AdministrationAnnual bed daysLarge health care systemAcute inpatient careSubstance abuse disordersHealth care systemImplementation of DRGsBed daysInpatient careMedical CenterAbuse disordersPsychiatric patientsPatientsCare systemCareProspective budgetingAverage lengthTotal numberYearsDirect expenditures